Sunday 11 October 2026 Export all SBRA data to Excel Powerpack

Sabra Healthcare REIT, Inc.

SBRA Real Estate Reit Healthcare Facilities

Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024. In the quarter to June 2026, revenue grew 24.7%, EPS fell 135.7%, free cash flow fell 666.1% and total debt rose 5.91%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three.

18.96 0.12 +0.64%
Market cap
$4.8B
P/E
72.9×
Fwd P/E
27.3×
Dividend yield
6.33%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Sabra Healthcare REIT, Inc. (SBRA) EV/Sales

Alert me on EV/Sales

As of 9 October 2026, Sabra Healthcare REIT, Inc. (SBRA) trades at a EV/Sales of 8.3×. Over the past ten years it has ranged from 5.2× (March 2020) to 18.0× (October 2017); the current reading is higher than 6% of that period. That is in line with the Reit Healthcare Facilities industry median of 8.3× and above the Real Estate sector median of 7.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 9.1× (0.34%)
FY2024 9.1× 4.26%
FY2023 8.7× 1.58%
FY2022 8.6× (6.75%)
FY2021 9.2× (6.40%)
FY2020 9.8× 2.57%
FY2019 9.6× (2.15%)
FY2018 9.8× (17.03%)
FY2017 11.8× 10.58%
FY2016 10.7× (2.66%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 8.5× (6.47%)
Mar 2026 9.1× 0.31%
Dec 2025 9.1× (1.49%)
Sep 2025 9.2× (0.32%)
42 more quarters

Against its own ten years

Low 5.2× High 18.0×
Ten-year median 9.8×
Current reading's percentile 7

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on SBRA